Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 22-Feb-17 7:49 PM View:  | Incyte Corp (INCY) | 17-Feb-17 | Grant | 10,610,800 | -- | -- | 20% 52.49M to 63.1M | |
| 05-Jan-17 7:00 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 03-Jan-17 | Grant | 42,507 | $1.50 | $63,760.50 | < 1% 10.42M to 10.47M | (90%) |
| 04-Jan-17 6:01 PM View: | Incyte Corp (INCY) | 30-Dec-16 | Grant | 567 | $100.27 | $56,853.10 | < 1% 23.75M to 23.75M | (13%) |
| 11-Oct-16 5:45 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 07-Oct-16 | Market Purchase | 3,250,000 | $2.00 | $6,500,000.00 | 45% 7.17M to 10.42M | (93%) |
| 05-Oct-16 4:30 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 03-Oct-16 | Grant | 24,897 | $2.56 | $63,736.30 | < 1% 7.15M to 7.17M | (94%) |
| 04-Oct-16 6:33 PM View: | Incyte Corp (INCY) | 30-Sep-16 | Grant | 603 | $94.29 | $56,856.90 | < 1% 23.75M to 23.75M | (7%) |
| 06-Jul-16 6:21 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 01-Jul-16 | Grant | 39,114 | $1.63 | $63,755.80 | < 1% 7.11M to 7.15M | (91%) |
| 05-Jul-16 5:13 PM View: | Incyte Corp (INCY) | 30-Jun-16 | Grant | 711 | $79.98 | $56,865.80 | < 1% 23.74M to 23.75M | 9% |
| 05-Apr-16 6:00 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 01-Apr-16 | Grant | 32,364 | $1.97 | $63,757.10 | < 1% 7.08M to 7.11M | (93%) |
| 04-Apr-16 6:32 PM View: | Incyte Corp (INCY) | 31-Mar-16 | Grant | 786 | $72.47 | $56,961.40 | < 1% 23.74M to 23.74M | 21% |
| 17-Mar-16 7:14 PM View: | Incyte Corp (INCY) | 17-Mar-16 | Option Exercise | 60,000 | $3.86 | $231,600.00 | < 1% 69.19M to 69.25M | |
| 17-Mar-16 7:14 PM View: | Incyte Corp (INCY) | 17-Mar-16 | Market Purchase | 400,000 | $61.49 | $24,595,800.00 | < 1% 69.25M to 69.65M | 42% |
| 17-Mar-16 7:14 PM View: | Incyte Corp (INCY) | 15-Mar-16 | Market Purchase | 400,000 | $66.47 | $26,588,400.00 | < 1% 68.79M to 69.19M | 31% |
| 26-Feb-16 10:00 PM View: | Incyte Corp (INCY) | 25-Feb-16 | Market Purchase | 6,700 | $74.00 | $495,800.00 | < 1% 22.88M to 22.88M | 18% |
| 26-Feb-16 10:00 PM View: | Incyte Corp (INCY) | 24-Feb-16 | Market Purchase | 57,590 | $70.41 | $4,055,190.00 | < 1% 22.82M to 22.88M | 24% |
| 16-Feb-16 10:00 PM View: | Incyte Corp (INCY) | 16-Feb-16 | Market Purchase | 678,488 | $70.71 | $47,973,400.00 | 3% 22.14M to 22.82M | 24% |
| 16-Feb-16 10:00 PM View: | Incyte Corp (INCY) | 12-Feb-16 | Market Purchase | 922,530 | $65.83 | $60,732,000.00 | 4% 21.01M to 21.93M | 33% |
| 16-Feb-16 10:00 PM View: | Incyte Corp (INCY) | 12-Feb-16 | Market Purchase | 208,677 | $67.14 | $14,010,400.00 | < 1% 21.93M to 22.14M | 30% |
| 16-Feb-16 10:00 PM View: | Incyte Corp (INCY) | 11-Feb-16 | Market Purchase | 1,328,900 | $61.93 | $82,297,696.00 | 7% 19.68M to 21.01M | 41% |
| 06-Jan-16 6:02 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 04-Jan-16 | Grant | 21,246 | $3.00 | $63,738.00 | < 1% 7.06M to 7.08M | (95%) |
| 05-Jan-16 6:22 PM View: | Incyte Corp (INCY) | 31-Dec-15 | Grant | 525 | $108.45 | $56,936.20 | < 1% 19.68M to 19.68M | (19%) |
| 05-Oct-15 6:59 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 01-Oct-15 | Grant | 20,835 | $3.06 | $63,755.10 | < 1% 7.04M to 7.06M | (95%) |
| 05-Oct-15 7:04 PM View: | Incyte Corp (INCY) | 01-Oct-15 | Grant | 516 | $110.33 | $56,930.30 | < 1% 19.68M to 19.68M | (21%) |
| 18-Sep-15 6:33 PM View: | Incyte Corp (INCY) | 16-Sep-15 | Option Exercise | 14,698 | -- | -- | < 1% 15.06M to 15.07M | |
| 18-Sep-15 6:33 PM View: | Incyte Corp (INCY) | 16-Sep-15 | Option Exercise | 4,609,230 | -- | -- | 31% 15.07M to 19.68M | |
| 06-Jul-15 6:25 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 01-Jul-15 | Grant | 15,780 | $3.66 | $57,754.80 | < 1% 7.02M to 7.04M | (96%) |
| 06-Jul-15 5:40 PM View: | Incyte Corp (INCY) | 01-Jul-15 | Grant | 546 | $104.21 | $56,898.70 | < 1% 15.06M to 15.06M | (16%) |
| 22-Jun-15 9:51 PM View: | Trimeris Inc. (GEVA) | 22-Jun-15 | Acquisition (other) | 99,503 | -- | -- | < 1% 11.88M to 11.98M | |
| 22-Jun-15 9:51 PM View: | Trimeris Inc. (GEVA) | 22-Jun-15 | Disposition (other) Duplicate | 1,807,720 | -- | -- | (15%) 11.98M to 10.17M | |
| 12-May-15 6:58 PM View: | Incyte Corp (INCY) | 11-May-15 | Option Exercise | 60,000 | $7.68 | $460,800.00 | < 1% 15.0M to 15.06M | |
| 02-Apr-15 7:09 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 01-Apr-15 | Grant | 16,410 | $3.52 | $57,763.20 | < 1% 7.0M to 7.02M | (96%) |
| 17-Feb-15 7:39 AM View: | Idera Pharmaceuticals, Inc. (ACGN) | 13-Feb-15 | Market Purchase | 5,333,330 | $3.75 | $20,000,000.00 | 319% 1.67M to 7.0M | (96%) |
| 09-Jan-15 5:28 PM View: | Trimeris Inc. (GEVA) | 07-Jan-15 | Private Purchase | 1,000,000 | $94.19 | $94,190,000.00 | 9% 10.88M to 11.88M | |
| 06-Jan-15 8:32 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 02-Jan-15 | Grant | 11,781 | $4.90 | $57,726.90 | < 1% 1.66M to 1.67M | (97%) |
| 03-Oct-14 5:55 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 01-Oct-14 | Grant | 26,742 | $2.16 | $57,762.70 | 2% 1.63M to 1.66M | (93%) |
| 03-Jul-14 2:32 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 01-Jul-14 | Grant | 18,546 | $2.83 | $52,485.20 | 1% 1.61M to 1.63M | (95%) |
| 23-May-14 5:07 PM View: | Incyte Corp (INCY) | 21-May-14 | Option Exercise | 30,000 | $7.02 | $210,600.00 | < 1% 14.97M to 15.0M | |
| 07-Mar-14 5:54 PM View: | Trimeris Inc. (GEVA) | 06-Mar-14 | Market Purchase Duplicate | 375,000 | $105.75 | $39,656,200.00 | 4% 10.42M to 10.79M | 123% |
| 27-Sep-13 4:08 PM View: | Trimeris Inc. (GEVA) | 25-Sep-13 | Market Purchase | 1,050,000 | $56.63 | $59,461,500.00 | 11% 9.37M to 10.42M | 316% |
| 13-Jun-13 6:49 PM View: | Incyte Corp (INCY) | 11-Jun-13 | Option Exercise | 30,000 | $4.44 | $133,200.00 | < 1% 14.94M to 14.97M | |
| 08-Jan-13 5:40 PM View: | Trimeris Inc. (GEVA) | 04-Jan-13 | Market Purchase | 859,720 | $47.53 | $40,862,500.00 | 10% 8.51M to 9.37M | 396% |
| 31-Oct-12 5:02 PM View: | XOMA Ltd. (XOMA) | 29-Oct-12 | Market Purchase | 4,722,670 | $3.00 | $14,168,000.00 | 30% 15.57M to 20.29M | (77%) |
| 03-Aug-12 5:35 PM View: | Incyte Corp (INCY) | 01-Aug-12 | Option Exercise | 10,000 | $5.67 | $56,700.00 | < 1% 14.9M to 14.91M | |
| 13-Jul-12 6:59 PM View: | Trimeris Inc. (GEVA) | 13-Jul-12 | Private Purchase Duplicate | 886,000 | $41.20 | $36,503,200.00 | 12% 7.62M to 8.51M | |
| 06-Jun-12 4:55 PM View: | Incyte Corp (INCY) | 04-Jun-12 | Option Exercise | 5,000 | $6.66 | $33,300.00 | < 1% 16.14M to 16.15M | |
| 23-May-12 5:03 PM View: | Genomic Health Inc. (GHDX) | 22-May-12 | Market Purchase | 17,406 | $32.94 | $573,401.00 | < 1% 11.36M to 11.38M | 153% |
| 23-May-12 5:03 PM View: | Genomic Health Inc. (GHDX) | 21-May-12 | Market Purchase | 150,000 | $32.18 | $4,826,970.00 | 1% 11.21M to 11.36M | 159% |
| 16-May-12 8:18 PM View: | Genomic Health Inc. (GHDX) | 16-May-12 | Market Purchase | 23,621 | $34.46 | $813,925.00 | < 1% 11.19M to 11.21M | 142% |
| 16-May-12 8:18 PM View: | Genomic Health Inc. (GHDX) | 15-May-12 | Market Purchase | 140,000 | $34.09 | $4,772,470.00 | 1% 11.05M to 11.19M | 144% |
| 16-May-12 8:18 PM View: | Genomic Health Inc. (GHDX) | 14-May-12 | Market Purchase | 212,438 | $33.68 | $7,153,900.00 | 2% 10.83M to 11.05M | 147% |